Immune function effects of dental amalgam in children A randomized clinical trial

Journal of the American Dental Association

Volumn 139, Issue 11, 2008, Pages 1496-1505

  Shenker, Bruce J ^a   Maserejian, Nancy N ^b   Zhang, Annie ^b,c   McKinlay, Sonja ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c PAREXEL INTERNATIONAL   (United States)

Author keywords

Dental amalgam; Immunotoxicity; Mercury

Indexed keywords

EID: 57349187210     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2008.0076     Document Type: Article

References (55)

1. Atchison WD, Hare MF. Mechanisms of methylmercury-induced neurotoxicity. FASEB J 1994;8(9):622-629.
2. Clarkson TW. The toxicology of mercury. Crit Rev Clin Lab Sci 1997;34(4):369-403.
3. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995;25(1):1-24.
4. World Health Organization. Concise International Chemical Assessment Document 50: Elemental Mercury and Inorganic Mercury Compounds: Human Health Aspects. Geneva: World Health Organization; 2003.
5. Dantas DC, Queiroz ML. Immunoglobulin E and autoantibodies in mercury-exposed workers. Immunopharmacol Immunotoxicol 1997; 19(3):383-392.
6. Dieter MP, Luster MI, Boorman GA, Jameson CW, Dean JH, Cox JW. Immunological and biochemical responses in mice treated with mercuric chloride. Toxicol Appl Pharmacol 1983;68(2):218-228.
7. Lawrence DA. Heavy metal modulation of lymphocyte activation, 1: in vitro effects of heavy metals on primary humoral immune responses. Toxicol Appl Pharmacol 1981;57(3):439-451.
8. Stejskal VD, Cederbrant K, Lindvall A, Forsbeck M. Melisa: an in vitro tool for the study of metal allergy. Toxic in Vitro 1994;8(5): 991-1000.
9. Stejskal VD, Forsbeck M, Cederbrant KE, Asteman O. Mercuryspecific lymphocytes: an indication of mercury allergy in man. J Clin Immunol 1996;16(1):31-40.
10. 2-induced autoimmunity. J Oral Pathol Med 1994; 23(10):441-445.
11. Gopinath C. Pathology of toxic effects on the immune system. Inflamm Res 1996;45(suppl 2):S74-S78.
12. Koropatnick J, Zalups RK. Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide- induced activation. Br J Pharmacol 1997;120(5):797-806.
13. Pollard KM, Hultman P. Effects of mercury on the immune system. In: Sigel A, Sigel H, eds. Mercury and Its Effects on Environment and Biology. New York City: Marcel Dekker; 1997:421-440. Metal Ions in Biological Systems; vol. 34.
14. Shenker BJ, Rooney C, Vitale L, Shapiro IM. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes, I: suppression of T-cell activation. Immunopharmacol Immunotoxicol 1992;14(3):539-553.
15. Shenker BJ, Datar S, Mansfield K, Shapiro IM. Induction of apoptosis in human T-cells by organomercuric compounds: a flow cytometric analysis. Toxicol Appl Pharmacol 1997;143(2):397-406.
16. Shenker BJ, Guo TL, Shapiro IM. Low-level metylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction. Environ Res 1998;77(2):149-159.
17. Shenker BJ, Guo TL, O I, Shapiro IM. Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol Appl Pharmacol 1999;157(1):23-35.
18. Via CS, Nguyen P, Niculescu F, Papadimitriou J, Hoover D, Silbergeld EK. Low-dose exposure 17 to iorganic mercury accelerates disease and mortality in acquired murine lupus. Environ Health Perspect 2003;111(10):1273-1277.
19. 2 cannot identify patients with systemic symptoms attributed to dental amalgam. J Dent Res 1999;78(8):1450-1458.
20. American Dental Association Survey Center. The 1999 Survey of Dental Services Rendered. Chicago: American Dental Association; 2002.
21. Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE. Amalgam exposure and neurological function. Neurotoxicology 2005; 26(2):241-255.
22. Factor-Litvak P, Hasselgren G, Jacobs D, et al. Mercury derived from dental amalgams and neuropsychologic function. Environ Health Perspect 2003;111(5):719-723.
23. Dalen K, Lygre GB, Koøve H, Gjerdet NR, Askevold E. Memory functions in persons with dental amalgam. J Dent 2003;31(7):487-492.
24. Nitschke I, Müller F, Smith J, Hopfenmüller W. Amalgam fillings and cognitive abilities in a representative sample of the elderly population. Gerontology 2000;17(1):39-44.
25. Björkman L, Pedersen NL, Lichtenstein P. Physical and mental health related to dental amalgam fillings in Swedish twins. Community Dent Oral Epidemiol 1966;24(4):260-267.
26. Saxe SR, Snowdon DA, Wekstein MW, et al. Dental amalgam and cognitive function in older women: findings from the Nun Study. JADA 1995;126(11):1495- 1501.
27. Mutter J, Naumann J, Sadaghiani C, Schneider R, Walach H. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuro Endocrinol Lett 2004;25(5):331-339.
28. Bates MN, Fawcett J, Garrett N, Cutress T, Kjellstrom T. Health effects of dental amalgam exposure: a retrospective cohort study. Int J Epidemiol 2004;33(4):894-902.
29. Trepka MJ, Heinrich J, Krause C, et al. Factors affecting internal mercury burdens among eastern German children. Arch Environ Health 1997;52(2):134-138.
30. Gabrio T, Benedikt T, Broser G, et al. 10 years of obsevation by public health offices in Baden-Wurttemberg-assessment of human biomonitoring for mercury due to dental amalgam fillings and other sources [in German]. Gesundheitswesen 2003;65(5):327-335.
31. Maserejian N, Trachtenberg F, Assmann S, Barregard L. Dental amalgam exposure measures and urinary mercury levels in children: The New England Children's Amalgam Trial. Environ Health Perspect 2008;116(2):256-262.
32. Levy M, Schwartz S, Dijak M, Weber JP, Tardif R, Rouah F. Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factors. Environ Res 2004;94(3):283-290.
33. Bellinger DC, Daniel D, Trachtenberg F, Tavares M, McKinlay S. Dental amalgam restorations and children's neurosychological function: the New England Children's Amalgam Trial. Environ Health Perspect 2006;115(3):440-446.
34. DeRouen TA, Martin MD, Leroux BG, et al. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA 2006;295(15):1784-1792.
35. Hornung R, Reed L. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 1990;51(1):46-51.
36. Barber TE, Wallis G. Correction of urinary mercury concentraton by specific gravity, osmolality and creatinine. J Occup Med 1986;28(5):354-359.
37. Barregard L. Mercury from dental amalgam: looking beyond the average. Occup Environ Med 2005;62(6):352-353.
38. Shenker BJ, Besack D, McKay TL, Pankoski L, Zekavat A, Demuth DR. Induction of cell cycle arrest in lymphocytes by Actinobacillus actinomycetemcomitans cytolethal distending toxin requires three subunits for maximum activity. J Immunol 2005;174(4): 2228-2234.
39. In Sug O, Datar S, Koch CJ, Shapiro IM, Shenker BJ. Mercuric compounds inhibit human monocyte function by inducing apoptosis: evidence for formation of reactive oxygen species, development of mitochondrial membrane permeability transition and loss of reductive reserve. Toxicol 1997;124(3):211-224.
40. Green LW. Manual for scoring socioeconomic status for research on health behavior. Public Health Rep 1970;85(9):815-827.
41. Shenker BJ, Berthold P, Decker S, et al. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes, II: alterations in cell viability. Immunopharmacol Immunotoxicol 1992;14(3): 555-577.
42. Shenker BJ, Berthold P, Rooney C, Vitale LA, DeBolt K, Shapiro IM. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes, III: alterations in B-cell function and viability. Immunopharmacol Immunotoxicol 1993;15(1):87-112.
43. Herrstrom P, Bratt I, Holmén A, Högstedt B. Micronuclei in lymphocyte subsets in relation to plasma mercury, dental amalgam and acrylate-containing tooth fillings. Sci Total Environ 2003;309(1-3): 253-255.
44. Shenker BJ, Mayro JS, Rooney C, Vitale LA, Shapiro IM. Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes, IV: alterations in cellular glutathione content. Immunopharmacol Immunotoxicol 1993;15(2-3):273-290.
45. Nakatsuru S, Oohashi J, Nozaki H, Nakada S, Imura N. Effect of mercurials on lymphocyte functions. Toxicol 1985;36(4):297-305.
46. Nordlind K. Inhibition of lymphoid cell DNA synthesis by metal allergens at various concentrations. Int Archs Allergy Appl Immunol 1983;70(2):191-192.
47. Castranova V, Bowman L, Reasor MJ, Miles PR. Effects of heavy metal ions on selected oxidative metabolic processes in rat alveolar macrophages. Toxicol Appl Pharmacol 1980;53(1):14-23.
48. Malamud D, Dietrich SA, Shapiro IM. Low levels of mercury inhibit the respiratory burst in human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1985;128(3):1145-1151.
49. Petruccioli L, Turillazzi P. Serum immunoglobulin levels in monkeys treated with methylmereury. Drug Chem Toxicol 1990;13(4): 297-307.
50. Henderson DC, Clifford R, Young DM. Mercury-reactive lymphocytes in peripheral blood are not a marker for dental amalgam associated disease. J Dent 2001;29(7):469-474.
51. Osorio E, Toledano M, Bravo M, Osorio R. Short-term changes in lymphocytes after placement of silver amalgam restorations in healthy subjects. Dent Mater 1995;11(5):323-326.
52. Yoshida M, Watanabe C, Horie K, Satoh M, Sawada M, Shimada A. Neurobehavioral changes in metallothionein-null mice prenatally exposed to mercury vapor. Toxicol Lett 2005;155(3):361-368.
53. Yoshida M, Watanabe C, Kishimoto M, et al. Behavioral changes in metallothionein-null mice after the cessation of long-term, low-level exposure to mercury vapor. Toxicol Lett 2006;161(3):210-218.
54. Soncini JA, Maserejian NN, Trachtenberg F, Tavares M, Hayes C. The longevity of amalgam versus compomer/composite restorations in posterior primary and permanent teeth: findings from the New England Children's Amalgam Trial. JADA 2007;138(6):763-772.
55. Bernardo M, Luis H, Martin MD, et al. Survival and reasons for failure of amalgam versus composite posterior restorations placed in a randomized clinical trial. JADA 2007;138(6):775-783.